Please Wait...

Klaus.Engelke

Translation skills

Main profile

Klaus Engelke
Klaus Engelke, PhD.
Director of Special Imaging Techniques

Professor Klaus Engelke received a Ph.D. in Physics from the University of Hamburg, Germany for his pioneering work on µCT using Synchrotron Radiation. Afterwards he joined the Osteoporosis Research Group at UCSF (University of California at San Francisco) to develop advanced radiographic methods for the diagnosis of osteoporosis. At UCSF he also developed the first workstation for vertebral fracture analysis using digitized x-rays. He then joined the newly formed Institute of Medical Physics (IMP) at the University of Erlangen, Germany to develop desktop µCT Scanners and advanced image processing methods. Prof. Engelke joined Synarc, now Bioclinica, as a Director of Special Imaging Techniques in 2005. At the University of Erlangen he continues to develop novel in vivo and in vitro image acquisition and analysis techniques for the musculoskeletal field. He has authored more than 250 peer reviewed publications and more than 350 conference contributions.

In 2007, 2013 and 2015 Prof. Engelke chaired or was member of the QCT Task Forces that developed the official positions of the International Society of Clinical Densitometry (ISCD). He is member of the committee for the development of the German guidelines for the diagnosis and treatment of osteoporosis under the auspices of the DVO ‘Dachverband Osteologie’. He is also a member of the scientific advisory committee of the International Osteoporosis Foundation (IOF) and co-chaired the Committee on Bone Densitometry of the International Commission on Radiation Units (ICRU). He was co-president of the German 2011 Osteology meeting and co-president of the 21st International Bone Densitometry Workshop and 7th European Symposium on Ultrasonic Characterization of Bone in 2017 in Banz, Germany

In 2017 he was awarded the Dr. John P. Bilezikian Global Leadership Award from the International Society for Clinical Densitometry, which recognizes Klaus for his contributions to the advancement of osteoporosis and bone imaging research. In 2019 he was awarded the ‘Excellence in Research Award’ from the European Calcified Tissue Society (ECTS) for his pioneering research in musculoskeletal imaging.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Clinical #datamanagement is essential to ensure high-quality data in #clinicaltrials, but the components are comple… https://t.co/klK81O6YA2
Bioclinica (16 hours ago)
Congratulations to Jeff Heilbraun, M.S., VP, Medical & Scientific Affairs, for his latest article on cardiovascular… https://t.co/JSuEaeQOYh
Bioclinica (5 days ago)
Changes are a fact of life - and of #clinicaltrial design. But planning and budgeting for your trial don’t have to… https://t.co/wsfMPAwLxR
Bioclinica (3 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/dYDJO4Qh7S
Bioclinica (3 weeks ago)
Our webinar on Neuroimaging in Parkinson’s Disease is tomorrow at 10:30 a.m. EDT. Register at:… https://t.co/4j0FGeXG0B
Bioclinica (3 weeks ago)
Today is World Ovarian Cancer Day. Ovarian cancer has the lowest survival rate of all female cancers. #Bioclinica p… https://t.co/1nMGahTMaz
Bioclinica (4 weeks ago)